BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2018
View Archived Issues
UCB to acquire Proximagen's midazolam nasal spray
Read More
EpimAb and Zhejiang Teruisi Biopharmaceutical enter development collaboration for FIT-012
Read More
GlaxoSmithKline describes novel TrpV4 antagonists
Read More
New phosphatidylinositol 3-kinase inhibitors identified at Gilead
Read More
Kalyra Pharmaceuticals presents novel ERK-1/2 inhibitors
Read More
BiopharmaTi divulges novel ketolide antibacterials
Read More
Roche discovers new gamma-secretase inhibitors
Read More
Sirolimus granted FDA orphan drug designation for the treatment of sickle cell disease
Read More
Sage submits NDA for intravenous brexanolone to treat postpartum depression
Read More
Prothena discontinues development of NEOD-001
Read More
Pfizer receives complete response letter from FDA for trastuzumab biosimilar
Read More
Voyager-V1 oncolytic virus under study in patients with solid tumors
Read More
FDA grants breakthrough therapy designation to Trumenba for children aged 1-9 years
Read More
CBT Pharmaceuticals and CrystalGenomics sign oncology codevelopment agreement
Read More
Autolus acquires rights to novel CD19 CAR T-cell therapy from UCL
Read More
E.U. approval for Mylotarg with chemotherapy for CD33-positive AML
Read More
FDA clears Ultragenyx's IND for phase I/II study of DTX-401 for glycogen storage disease type Ia
Read More
Novel PIM/PI3K inhibitor IBL-302 shows promise in preclinical cancer models
Read More
Astellas seeks Japanese and U.S. approval for gilteritinib in FLT3 mutation-positive AML
Read More
AOBiome Therapeutics initiates phase II study of ammonia oxidizing bacteria product candidate
Read More
Connect Biopharmaceuticals files to begin phase I study of CBP-201 in Australia
Read More
FDA advisory committee recommends baricitinib 2 mg, rejects 4-mg dose in rheumatoid arthritis
Read More
EMA validates type II variation for Keytruda with pemetrexed and chemotherapy in NSCLC
Read More
Q Therapeutics and Reprocell create joint venture
Read More
FDA issues partial clinical hold for tazemetostat trials
Read More
Researchers present potent EGFR T790M-mutant inhibitor E-191
Read More
AstraZeneca reports data from ARCTIC study of Imfinzi and tremelimumab in third-line NSCLC
Read More
Novel selective estrogen receptor degrader LX-039 selected for clinical development
Read More
Atozet launched in Japan
Read More
FDA grants fast track designation to AAV-RPGR
Read More
Malaria vaccine R-21 shows efficacy in a phase IIa trial
Read More
Celgene launches Istodax in Japan
Read More